CRLVSGTBP• 28 Days (Normalized)
CRL vs GTBP (Charles River Laboratories International Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Sep 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CRL Performance $290.19
+3.36%
Charles River Laboratories International Inc.
Normalized Baseline0.00%
GTBP Performance $6.1
+2.01%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin CRL LEADS
+1.35 pts
CRL outperforming by 1.35 percentage points
CRLGTBP
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CRL GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | CRL Price | CRL Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $290.19 | +3.36% | $6.10 | +2.01% | +1.35% |
| Oct 01, 2026 | $286.83 | +2.16% | $- | - | |
| Sep 30, 2026 | $295.01 | +5.08% | $- | - | |
| Sep 29, 2026 | $295.96 | +5.41% | $6.88 | +14.97% | -9.56% |
| Sep 28, 2026 | $294.59 | +4.93% | $6.80 | +13.71% | -8.78% |
| Sep 25, 2026 | $292.84 | +4.30% | $6.89 | +15.22% | -10.92% |
| Sep 24, 2026 | $- | $6.83 | +14.21% | - | |
| Sep 23, 2026 | $277.33 | -1.22% | $7.10 | +18.73% | -19.95% |
| Sep 22, 2026 | $285.11 | +1.55% | $- | - | |
| Sep 21, 2026 | $279.01 | -0.62% | $7.18 | +20.07% | -20.69% |
| Sep 18, 2026 | $278.06 | -0.96% | $7.16 | +19.73% | -20.69% |
| Sep 17, 2026 | $281.67 | +0.32% | $7.49 | +25.25% | -24.93% |
| Sep 16, 2026 | $273.41 | -2.62% | $7.81 | +30.60% | -33.22% |
| Sep 15, 2026 | $272.88 | -2.81% | $9.00 | +50.50% | -53.31% |
| Sep 14, 2026 | $273.11 | -2.72% | $11.63 | +94.48% | -97.20% |
Page 1 of 2